You are not logged in.

Cyclooxygenase-2 (COX-2) inhibitors RFP

Details

Tender Closed
RFx ID : 17743670
Tender Name : Cyclooxygenase-2 (COX-2) inhibitors RFP
Reference # : A926600
Open Date : Monday, 1 August 2016 9:30 AM (Pacific/Auckland UTC+12:00)
Close Date  : Friday, 26 August 2016 5:00 PM (Pacific/Auckland UTC+12:00)
Tender Type : Request for Proposals (RFP)
Tender Coverage : Sole Agency  [?]
Categories :
  • 51000000 - Drugs and Pharmaceutical Products
Regions:
  • New Zealand
Exemption Reason : None
Required Pre-qualifications : None
Contact : Chloë Dimock
procurement@pharmac.govt.nz
Alternate Physical Delivery Address  :
Alternate Physical Fax Number  :
Agency Address :
Overview

REQUEST FOR PROPOSALS – SUPPLY OF SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITORS

PHARMAC invites proposals for the supply of selective cyclooxygenase-2 (COX-2) inhibitors in New Zealand; specifically, celecoxib and etoricoxib.

The attached request for proposals (RFP) letter incorporates the following schedules:
· Schedule 1 specifies the pharmaceuticals for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
· Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
· Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
· Schedule 4 contains the RFP form in which you are to provide details of your proposal.

If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 5.00 p.m. on 26 August 2016

If you have any questions about this RFP, please post these on GETS or alternatively contact Chloë Dimock by email at procurement@pharmac.govt.nz at PHARMAC.

We look forward to receiving your proposal.

RFx Outcome

This tender has been awarded to:

  • Pfizer New Zealand Ltd

Further Award Information:
PHARMAC is pleased to announce the approval of an agreement with Pfizer New Zealand Ltd for the supply of celecoxib.

For full details please refer to our website: https://www.pharmac.govt.nz/news/notification-2016-12-05-cox-2-inhibitors-pfizer/

Award Date: Tuesday, 6 December 2016 (Pacific/Auckland UTC+13:00)
Date RFx was completed/updated: Monday, 29 August 2016 9:29 AM (Pacific/Auckland UTC+12:00)